FDA Class 1 Recall – PHILIP® Ventilators, including CPAP and BiPAP Devices.
If you regularly used a PHILIPS® Ventilator and developed a respiratory disease or certain cancers, you may be entitled to financial compensation.​Importantly, users of recalled Ventilators, CPAP and BiPAP devices have been advised to stop using the recalled devices immediately and talk to their health care provider about treatment alternatives.  A Class 1 Recall is the most serious and urgent of the FDA’s recalls.
​
​On June 30th, 2021, the FDA alerted those using certain Philips® Respironics Ventilators – BiPAP – and CPAP machines manufactured between 2009 and April 2021 of potential health risks associated with the polyester-based polyurethane (PE-PUR) sound reduction foam. The PE-PUR foam can break down and possibly enter the device’s air corridor. Should this occur, black debris from the PE-PUR foam and/or certain potentially cancer-causing substances released into the device’s air corridor can be inhaled or swallowed by the persons using the device.

FDA Class 1 Recall – PHILIP® Ventilators, including CPAP and BiPAP Devices.
If you regularly used a PHILIPS® Ventilator and developed a respiratory disease or certain cancers, you may be entitled to financial compensation.

If you or a loved one used one of the affected devices and developed one or more of the conditions listed below, contact the Louisiana CPAP Claims Attorneys at Lundy LLP for a free case evaluation.
​
To date, the recall includes the following Continuous Ventilator, Minimum Ventilatory Support, Facility Use E30 CPAP and BiPAP Devices manufactured between 2009 and April 2021:

​Continuous Ventilator, Non-life Supporting       

• DreamStation ASV
• DreamStation ST, AVAPS
• SystemOne ASV4
• C-Series ASV
• C-Series S/T and AVAPS
• OmniLab Advanced+

Noncontinuous Ventilator 

• SystemOne (Q-Series)
• DreamStation
• DreamStation Go
• Dorma 400
• Dorma 500
• REMstar SE Auto

Continuous Ventilator 

• Trilogy 100
• Trilogy 200
• Garbin Plus, Aeris, LifeVent

Continuous Ventilator, Minimum Ventilatory Support, Facility Use

• A-Series BiPAP V30 Auto Continuous Ventilator, Non-life Supporting
• A-Series BiPAP A40
• A-Series BiPAP A30

​Note: The newly launched DreamStation 2 has NOT been recalled; it is not affected by the presence of PE-PUR. The A-Series BiPAP Hybrid A30 is recalled, but is not marketed in the U.S.

The science behind the claims is in early stages, and it is not clear which types of cancer can be definitively linked to the use of these recalled devices. It is believed the following cancers may be related to inhaling gases emitted from polyurethane foam; however, these are currently being reviewed by experts.​

In addition to cancer, exposure to polyurethane foam gases may be linked to Respiratory Disease. ​

​Lundy LLP is a personal injury law firm representing Philips® Ventilators, BiPAP and CPAP users in the U.S. We are investigating cases where the patient used one (or more) of the recalled Philips® devices and was diagnosed with one or more of the relevant health conditions.
​
​We are bringing lawsuits to help victims recover compensation for medical bills, lost wages, and pain and suffering.